Before a heart attack or stroke, an enzyme in platelets accelerates platelet clotting, the researchers found. As a result, they developed a drug that can temporarily inhibit platelet clotting, thus avoiding blood vessel blockage and preventing heart disease and stroke.
At present, the drug has achieved good results in animal model experiments, and researchers are preparing for the next phase of human clinical trials. The research results have been published in Science Translational Medicine.
This article source: Xinhuanet editor in charge: Wang Fengzhi_ NT2541